Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedA new version of the Teclistamab multiple myeloma trial record was added, documenting a Study Status change.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check21 days agoChange DetectedA notice was added about NIH website changes, including an announcement that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check28 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check49 days agoChange DetectedVersion 92 was added to the history on 2026-09-25 with a Study Status update. An older entry dated 2026-08-28 was removed.SummaryDifference0.2%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.